Government of Denmark   Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4
Founded: Copenhagen Denmark (1848)

Organization Overview

First Clinical Trial
1998
NCT00206960
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Capital Region, Copenhagen, Denmark | Capital Region Pharmacy, Denmark | Center of Clinical Research, Regional Hospital North Jutland, Hjørring, Denmark | Copenhagen Municipality, Denmark | Danish Center of Particle Therapy | Danish Committee for Health Education | Danish Comprehensive Cancer Center | Danish Lymphoma Group | Danish Study Group | Danish Veterans Centre | Emergency Medical Services, Capital Region, Denmark | Fund for Research, Quality and Education in Physiotherapy Practice | Independent Research Fund Denmark | Kolding Municipality, Denmark | Mental Health Services Capital Region Denmark | Mental Health Services in the Capital Region of Denmark | Military Psychology Department, Danish Veteran Centre | Ministery of Economic affairs | Ministry of the Interior and Health, Denmark | Municipalities of Northern Jutland, Denmark | Municipality of Herlev | Municipality of Koege, Denmark | Municipality of Odense | National Allergy Research Center | National Allergy Research Center, Denmark | National Board of Health, Denmark | North Denmark Region | Northern Orthopaedic Division, Denmark | Region Capital Denmark | Sten Rasmussen, MD, PhD | The Danish Committee of Health Education | The Danish Medical Research Council | The Ministry of Science, Technology and Innovation, Denmark | The Municipality of Odense, Denmark | Tværspuljen

Active Ingredients

Drugs in Phase 4 Trials (14)

aripiprazole (abilify) (1 trial)

bnt162b2 (Comirnaty) (1 trial)

chadox1 (1 trial)

chlorzoxazone (parafon forte dsc) (1 trial)

enalapril (vasotec) (1 trial)

escitalopram (lexapro) (1 trial)

esomeprazole (nexium) (1 trial)

methylphenidate (ritalin) (2 trials)

mirtazapine (remeron) (1 trial)

mrna-1273 (Spikevax) (1 trial)

oxygen (2 trials)

polidocanol (asclera) (1 trial)

quetiapine (seroquel) (3 trials)

ropivacaine (naropin) (1 trial)

Drugs in Phase 3 Trials (7)

albumin (Human) (Plasbumin) (1 trial)

bacille calmette-guerin (1 trial)

clarithromycin (biaxin) (1 trial)

iloprost (ventavis) (1 trial)

immune globulin (human) (Gamastan) (1 trial)

letrozole (femara) (3 trials)

melatonin (1 trial)

Drugs in Phase 2 Trials (8)

alecsat (1 trial)

calcium (1 trial)

cisplatin (platinol) (1 trial)

epoetin (Epogen) (1 trial)

gemcitabine (gemzar) (1 trial)

progesterone (progestasert) (1 trial)

teriparatide (1 trial)

tislelizumab (1 trial)

Drugs in Phase 1 Trials (12)

afo-18 (2 trials)

autologous bone graft (1 trial)

bone morphogenetic protein-2 (1 trial)

ferrous fumarate (1 trial)

glucosamine (1 trial)

ibudilast (1 trial)

ibuprofen (motrin) (2 trials)

iron (1 trial)

lidocaine (xylocaine) (2 trials)

mecasermin (Increlex) (1 trial)

sodium chloride (1 trial)

vitamin d3 (1 trial)

Drugs in Other Trials (28)

acetaminophen (tylenol) (2 trials)

amiloride (midamor) (1 trial)

autologous microbiome (1 trial)

cow milk (1 trial)

elemental gold (2 trials)

epinephrine (levophed) (1 trial)

glucagon-like peptide-1 (1 trial)

high-selenium yeast (1 trial)

hydrolyzed casein (2 trials)

imipramine (tofranil) (1 trial)

ketorolac (acuvail) (1 trial)

lactobacillus plantarum (1 trial)

lamotrigine (lamictal) (1 trial)

levobupivacaine (chirocaine) (1 trial)

maltodextrin (2 trials)

methylprednisolone (medrol) (1 trial)

mexiletine (mexitil) (1 trial)

morphine (1 trial)

nickel sulfate hexahydrate (1 trial)

nicotine (nicorette) (1 trial)

pantoprazole (protonix) (2 trials)

red clover extract (1 trial)

resveratrol (5 trials)

risperidone (risperdal) (1 trial)

sodium aluminium phospate (1 trial)

somatostatin (1 trial)

whey protein (1 trial)

zuclopenthixol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Abortion, Habitual (Phase 3)

Abortion, Spontaneous (Phase 3)

Acquired Immunodeficiency Syndrome (Phase 1)

Acute Coronary Syndrome (Phase 4)

Bipolar Disorder (Phase 2)

Bone Diseases (Phase 1)

Breast Neoplasms (Phase 3)

Cardiovascular Diseases (Phase 3)

Coronary Artery Disease (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Disease (Phase 4)

Dyspepsia (Phase 4)

Fractures, Bone (Phase 2)

Headache (Phase 1)

Heart Diseases (Phase 3)

Hip Fractures (Phase 2)

HIV Infections (Phase 1)

Infections (Phase 1)

Infertility (Phase 3)

Mental Disorders (Phase 4)

Migraine Disorders (Phase 1)

Mood Disorders (Phase 4)

Myocardial Ischemia (Phase 3)

Neoplasm Metastasis (Phase 3)

Osteoarthritis (Phase 4)

Osteoarthritis, Hip (Phase 4)

Osteoarthritis, Knee (Phase 4)

Pain, Postoperative (Phase 1)

Premature Birth (Phase 2)

Psychotic Disorders (Phase 4)

Shock (Phase 3)

Shock, Septic (Phase 3)

Shoulder Fractures (Phase 2)

Tendinopathy (Phase 4)

Tibial Fractures (Phase 1)

Triple Negative Breast Neoplasms (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 64
  • # of Trial APIs: 69